Back to mobile site

WAVE Life Sciences (WVE) PT Lowered to $21 at BofA Securities

March 26, 2026 12:30 PM EDT Send to a Friend
BofA Securities analyst Alec Stranahan lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $21.00 (from $38.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login